What is the address of VERMEYEN ELS DR.?

The registered office of VERMEYEN ELS DR. is located at Gestelsedijk 71, 3920 Lommel.

Is VERMEYEN ELS DR. still active?

Yes. According to the CBE (30 October 2026) VERMEYEN ELS DR. is active, legal situation “Normale toestand”, started on 24 July 2019.

Is VERMEYEN ELS DR. registered on Peppol?

Yes, VERMEYEN ELS DR. is registered on the Peppol network with ID 0208:0731564892.

What is the enterprise number of VERMEYEN ELS DR.?

The enterprise number of VERMEYEN ELS DR. is BE0731564892.

When was VERMEYEN ELS DR. founded?

VERMEYEN ELS DR. was founded on 24 July 2019.

Who are the directors of VERMEYEN ELS DR.?

According to the 2025 annual accounts, the directors of VERMEYEN ELS DR. are: ELS VERMEYEN.

Is VERMEYEN ELS DR. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 July 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did VERMEYEN ELS DR. make in 2025?

VERMEYEN ELS DR. posted a profit after taxes of € 151,466 in financial year 2025.

What is the revenue of VERMEYEN ELS DR.?

As a small company, VERMEYEN ELS DR. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 190,704.

VERMEYEN ELS DR. (Private Limited) - Lommel

Dossier VERMEYEN ELS DR., printed on 30 October 2026 from databakkes.be/en/0731564892/vermeyen-els-dr. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VERMEYEN ELS DR. from Lommel, company number BE0731564892, closed financial year 2025 with a result of € 151,466 after tax. For that financial year VERMEYEN ELS DR. recorded a gross margin of € 190,704 and equity of € 181,387. Compared with financial year 2024, the result moved from € 145,275 to € 151,466. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 181,387

▼ 40% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 151,466

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 126,122

▼ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 272,458 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,864

▲ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,338

▼ 44% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 162,727 Gross margin 2022: € 162,727 First fiscal year in the series	€ 149,058 Gross margin 2023: € 149,058 ▼ 8% vs 2022 (€ 162,727) Unfavourable step	€ 181,351 Gross margin 2024: € 181,351 ▲ 22% vs 2023 (€ 149,058) Favourable step	€ 190,704 Gross margin 2025: € 190,704 ▲ 5% vs 2024 (€ 181,351) Favourable step	▲ 5%
Profit after taxes	€ 120,534 Profit after taxes 2022: € 120,534 First fiscal year in the series	€ 117,101 Profit after taxes 2023: € 117,101 ▼ 3% vs 2022 (€ 120,534) Unfavourable step	€ 145,275 Profit after taxes 2024: € 145,275 ▲ 24% vs 2023 (€ 117,101) Favourable step	€ 151,466 Profit after taxes 2025: € 151,466 ▲ 4% vs 2024 (€ 145,275) Favourable step	▲ 4%
Equity	€ 302,379 Equity 2022: € 302,379 First fiscal year in the series	€ 302,379 Equity 2023: € 302,379 Unchanged (€ 302,379) Unchanged	€ 302,379 Equity 2024: € 302,379 Unchanged (€ 302,379) Unchanged	€ 181,387 Equity 2025: € 181,387 ▼ 40% vs 2024 (€ 302,379) Unfavourable step	▼ 40%
Total debts	€ 164,783 Total debts 2022: € 164,783 First fiscal year in the series	€ 124,032 Total debts 2023: € 124,032 ▼ 25% vs 2022 (€ 164,783) Favourable step	€ 153,192 Total debts 2024: € 153,192 ▲ 24% vs 2023 (€ 124,032) Unfavourable step	€ 157,293 Total debts 2025: € 157,293 ▲ 3% vs 2024 (€ 153,192) Unfavourable step	▲ 3%
Cash	€ 370,213 Cash 2022: € 370,213 First fiscal year in the series	€ 113,210 Cash 2023: € 113,210 ▼ 69% vs 2022 (€ 370,213) Unfavourable step	€ 249,015 Cash 2024: € 249,015 ▲ 120% vs 2023 (€ 113,210) Favourable step	€ 126,122 Cash 2025: € 126,122 ▼ 49% vs 2024 (€ 249,015) Unfavourable step	▼ 49%
Retained profit	€ 296,379 Retained profit 2022: € 296,379 First fiscal year in the series	€ 296,379 Retained profit 2023: € 296,379 Unchanged (€ 296,379) Unchanged	€ 296,379 Retained profit 2024: € 296,379 Unchanged (€ 296,379) Unchanged	€ 175,387 Retained profit 2025: € 175,387 ▼ 41% vs 2024 (€ 296,379) Unfavourable step	▼ 41%
Dividend	€ 120,534 Dividend 2022: € 120,534 First fiscal year in the series	€ 117,101 Dividend 2023: € 117,101 ▼ 3% vs 2022 (€ 120,534) Unchanged	€ 145,275 Dividend 2024: € 145,275 ▲ 24% vs 2023 (€ 117,101) Unchanged	€ 272,458 Dividend 2025: € 272,458 ▲ 88% vs 2024 (€ 145,275) Unchanged	▲ 88%
Balance sheet total	€ 467,162 Balance sheet total 2022: € 467,162 First fiscal year in the series	€ 426,411 Balance sheet total 2023: € 426,411 ▼ 9% vs 2022 (€ 467,162) Unchanged	€ 455,571 Balance sheet total 2024: € 455,571 ▲ 7% vs 2023 (€ 426,411) Unchanged	€ 338,680 Balance sheet total 2025: € 338,680 ▼ 26% vs 2024 (€ 455,571) Unchanged	▼ 26%

Key figures of VERMEYEN ELS DR., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VERMEYEN ELS DR.?

What happened at VERMEYEN ELS DR. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 151,466 (▲ 4% vs 2024). Source: NBB ↗
Jul 24, 2019 New establishment in Lommel. KBO
2019 ELS VERMEYEN became a director. NBB
Jul 24, 2019 Start of the company according to the CBE. KBO

In short

From € 120,534 profit in 2022 to € 151,466 profit in 2025.

Paid € 158,198 in corporate taxes since 2022.

Best year ever: 2025, with € 151,466 profit.

Paid out € 655,368 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

ELS VERMEYEN

VERMEYEN ELS DR.

Associatie Inwendige Geneeskunde Maria Ziekenhuis Noord Limburg

Behind VERMEYEN ELS DR. is ELS VERMEYEN. ELS VERMEYEN is also behind Associatie Inwendige Geneeskunde Maria Ziekenhuis Noord Limburg.

Directors

According to the 2025 annual accounts

ELS VERMEYEN

Director

Also active at: Associatie Inwendige Geneeskunde Maria Ziekenhuis Noord Limburg

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Gestelsedijk 71

3920 Lommel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0731.564.892
VAT number: BE 0731.564.892
Registered office: Gestelsedijk 71, 3920 Lommel
Names & denominations: VERMEYEN ELS DR.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 July 2019
Peppol: Active · Active since 19 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗